Close Menu

NEW YORK (GenomeWeb) – Natera reported after the close of the market on Tuesday that its second quarter 2017 revenues were up 3 percent.

The San Carlos, California-based molecular diagnostics company reported total Q2 2017 revenues of $53.6 million compared to $52.0 million in Q2 2016, beating analysts' average estimate of $50.6 million. Total revenues included $52.3 million in product revenue and $1.3 million in licensing and other revenue.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
27
Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.